Loading…
Allimax Us was warned for selling unapproved allicin-based capsules, creams, gels, sprays, and liquids through its website and social media platforms with claims that these products could mitigate, prevent, treat, diagnose, or cure COVID-19. The products violated the Federal Food, Drug, and Cosmetic Act by being marketed as unapproved new drugs (section 505(a)) and misbranded drugs (section 502). The FDA took enforcement action during the declared public health emergency and national emergency related to COVID-19, prioritizing removal of unauthorized products making disease claims from the marketplace.